Acorns and inhalers: The Asthma Clinical Research Network

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 1, 2007, Pages 28-29

  Drazen, Jeffrey M ^a   Lenfant, Claude ^b   Hurd, Suzanne S ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Global Initiative for Asthma   (United States)

Author keywords

albuterol; Beta agonists; pharmacogenetics

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ALLERGIC ASTHMA; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL STUDY; EDITORIAL; EXPIRATORY FLOW; GENETICS; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INHALER; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; POWDER; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIALS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEBULIZERS AND VAPORIZERS; RESEARCH; UNITED STATES;

EID: 33845949769     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.06.011     Document Type: Editorial

References (2)

1. Drazen J.M., Israel E., Boushey H.A., Chinchilli V.M., Fahy J.V., Fish J.E., et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 335 (1996) 841-847
2. Israel E., Chinchilli V.M., Ford J.G., Boushey H.A., Cherniack R., Craig T.J., et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364 (2004) 1505-1512